Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Edwards Lifesciences (NY: EW )

68.93 -0.11 (-0.16%)
Official Closing Price Updated: 7:00 PM EST, Jan 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Edwards Lifesciences

< Previous 1 2 3 4 5 Next >
Kaplan Fox &amp; Kilsheimer LLP Alerts Investors to a Securities Class Action Against Edwards Lifesciences Corp. (EW) - Deadline is December 13, 2024
NEW YORK, NY - (NewMediaWire) - October 16, 2024 - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Edwards Lifesciences Corporation (“Edwards Lifesciences” or... 
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal
Edwards Lifesciences Corporation (EW) Investors: December 13, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: Investors With Large Losses in Edwards Lifesciences Corporation Should Contact Bernstein Liebhard LLP To Discuss Their Rights
From Bernstein Liebhard LLP
Via GlobeNewswire
Investor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against Edwards Lifesciences Corporation
From Robbins LLP
Via GlobeNewswire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Edwards Lifesciences Corporation (EW) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Edwards Lifesciences Corporation (EW) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Edwards Lifesciences Corporation (EW) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
EDWARDS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Edwards Lifesciences Corp and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Rosen Law Firm Urges Edwards Lifesciences Corporation (NYSE: EW) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
EW INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation
From Faruqi & Faruqi LLP
Via GlobeNewswire
Edwards Lifesciences Completes Sale of Critical Care
From Edwards Lifesciences Corporation
Via Business Wire
CORRECTING and REPLACING First All-Female TAVI Trial Shows Excellent Outcomes for Women Receiving Edwards Valves
From Edwards Lifesciences Corporation
Via Business Wire
Edwards Lifesciences to Present at the 2024 Wells Fargo Healthcare Conference
From Edwards Lifesciences Corporation
Via Business Wire
Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix
From Edwards Lifesciences Corporation
Via Business Wire
Edwards Lifesciences Reports Second Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
Edwards Lifesciences to Host Earnings Conference Call on July 24, 2024
From Edwards Lifesciences Corporation
Via Business Wire
Edwards Lifesciences to Acquire Innovalve
From Edwards Lifesciences Corporation
Via Business Wire
Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR
From Edwards Lifesciences Corporation
Via Business Wire
Edwards Lifesciences to Sell Critical Care to BD
From Edwards Lifesciences Corporation
Via Business Wire
Edwards Lifesciences Reports First Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024
From Edwards Lifesciences Corporation
Via Business Wire
The 5 Stocks Most Sold By Insiders This Year
Insiders are selling these 5 stocks increased as their markets advanced, and gains may be capped. Long-term outlooks are positive for growth and share prices. 
Via MarketBeat
Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It
From Edwards Lifesciences Corporation
Via Business Wire
Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR
From Edwards Lifesciences Corporation
Via Business Wire
Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
From Edwards Lifesciences Corporation
Via Business Wire
Can financial, healthcare, energy stocks rise as rates stay high?
Sectors including financials, healthcare, utilities and energy outperform as interest rates remain high, but some of those industries face challenges in 2024. 
Via MarketBeat
Edwards Lifesciences Reports Fourth Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve
From Edwards Lifesciences Corporation
Via Business Wire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.